...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

Although it is a meaningless gesture I chose to withhold my vote for Don M at the board level.  I am hoping enough people follow suit to make the board reconsider his position.  Something has to shake this company ( and RVX) up and get things moving. Money seems to be flowing freely to other companies with less promising science.  Show me the money and let me exit this dog with at least my money back. My ego can handle the hit, my wallet,  not so much. 

Share
New Message
Please login to post a reply